Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BALANCE 2
2006-001317-15Phase 4Terminated
- Sponsor
- University of Oxford
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of quetiapine and lamotrigine in bipolar disorder (BD) (3 arms), sponsored by University of Oxford. Primary endpoint: Change in QIDS-C16 total score at 12 weeks. Started Apr 2006; status: terminated.
02
Drugs
quetiapinelamotrigine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on 2006-001317-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001317-15.